Company Directory

Global biopharma with UK manufacturing, commercial and clinical operations

MSD is a global biopharmaceutical company discovering, developing, manufacturing and marketing medicines and vaccines across oncology, infectious disease, immunology, cardiometabolic disease and animal health. Its UK operations span pharmaceutical manufacturing at Cramlington, Northumberland, which supplies medicines into the Merck global network, alongside commercial and clinical development functions headquartered at Moorgate, London, and an Animal Health division based in Milton Keynes. MSD conducts approximately 150 clinical studies in the UK annually.

Pharmaceutical formulation development and clinical manufacturing services

SGS Quay Pharma is a contract development and manufacturing organisation providing formulation development, analytical services, and clinical trial manufacturing for pharmaceutical and biotechnology companies. The company specialises in dosage form design for APIs with challenging solubility and bioavailability profiles, and in modified and controlled release formulations. Operating from a MHRA and FDA-approved facility in North Wales, it supports clients from preclinical stage through to Phase III and commercial manufacture.

Chiral and achiral chromatography services for small molecule purification

Reach Separations is a contract chromatography company specialising in the analysis and purification of small molecules for clients in the pharmaceutical, agrochemical, and fine chemical sectors. Using HPLC and SFC technologies, the company provides chiral and achiral separation services from discovery scale through to kilogram-scale purification, supporting medicinal chemistry and drug development programmes. Services include impurity isolation, compound library QC, and LC-MS analysis.

Lyophilisation equipment, CDMO services, and freeze-drying expertise

Biopharma Group is a contract development and manufacturing organisation and capital equipment supplier specialising in lyophilisation and liquid formulation technologies. The company serves pharmaceutical, biotechnology, and diagnostics clients across two divisions: an equipment sales and technical service division supplying freeze dryers, aseptic fill-finish lines, and cryogenic storage systems; and a CDMO division providing formulation development, cycle development, and GMP and non-GMP contract manufacturing.

Biopharmaceutical group distributing and developing cannabis-based medicines

GROW Group is a biopharmaceutical company focused exclusively on cannabis-based medicines, operating through complementary distribution and research divisions. Its UK distribution arm, Grow Group UK, is a licensed GMP specials manufacturer supplying prescribed cannabinoid medicines to patients via specialist physicians. Its R&D division, GROW Biotech, develops cannabinoid extraction, purification, and delivery technologies at its Harpenden laboratory. The group serves patients, prescribers, and international cannabis producers, and holds patents on novel cannabinoid processing methods.

Global biopharma with major UK R&D and regulatory operations

Pfizer Limited is the principal UK subsidiary of Pfizer Inc., one of the world's largest biopharmaceutical companies. Its Sandwich, Kent site houses pharmaceutical sciences, global clinical supplies, quality assurance, and worldwide safety and regulatory operations serving over 175 markets. A Devices Centre of Excellence in Cambridge specialises in drug delivery device development. The UK operation supports clinical trials across dozens of UK sites and conducts R&D spanning small molecules, vaccines, oncology and inflammation.

European specialty pharma focused on gastroenterology and hepatology

Norgine is a European specialty pharmaceutical company developing, manufacturing, and commercialising medicines across gastroenterology, hepatology, and cancer supportive care. Founded in 1906 and privately owned, the company markets a portfolio of specialty pharmaceutical products and medical devices across Europe, Australia, and New Zealand. Its primary UK manufacturing and R&D site in Hengoed, Wales employs over 600 people and produces approximately 50 million packs of medicines annually. Norgine supplements its internal pipeline through selective in-licensing partnerships.

Aseptic fill-finish and pharmaceutical manufacturing equipment

3P Innovation is a UK-based engineering company designing and manufacturing automated equipment and modular systems for pharmaceutical and medical device production. The company specialises in aseptic fill-finish platforms, isolator integration and precision automation technologies supporting drug development from R&D through to commercial manufacturing. 3P Innovation provides configurable manufacturing systems and engineering services to pharmaceutical companies and CDMOs requiring compliant, scalable and high-precision production equipment.

Enzyme indicator technology for hydrogen peroxide bio-decontamination

Protak Scientific manufactures Enzyme Indicator technology, a rapid validation tool for measuring hydrogen peroxide gaseous bio-decontamination efficacy in pharmaceutical manufacturing and cleanroom environments. Developed in collaboration with Public Health England, the system delivers results in 60 seconds and is used to validate aseptic isolators, pass-through chambers, and filling lines. The company also provides validation consultancy and a real-time compliance reporting platform, serving over 80% of the world's largest pharmaceutical companies.

Analytical instruments, consumables and services for life science laboratories

Agilent Technologies LDA UK Limited is the principal UK subsidiary of Agilent Technologies, Inc., a global provider of analytical instruments, software, consumables, and services for life science, diagnostic, and applied chemical laboratories. UK operations include a major R&D facility at Harwell Campus housing the Raman spectroscopy business and Laser Spectroscopy Center of Excellence, alongside UK commercial and distribution operations based in Cheadle. Products span chromatography, mass spectrometry, spectroscopy, genomics, and flow cytometry.

Integrated formulation, GMP manufacture and Phase I clinical trials

BDD Pharma is a contract research and manufacturing organisation offering an integrated Lean Clinical Development pathway that combines formulation development, GMP manufacture, and Phase I clinical trials under one roof. The approach eliminates handoffs between separate service providers, reducing time to first-in-human data. BDD also develops its own drug delivery technologies, including a patented delayed-release oral tablet system. The company operates from two Glasgow sites and serves pharmaceutical clients globally.

AI-driven automated flow chemistry platform for chemical process development

SOLVE Chemistry is a contract research and technology company providing AI-powered process development services to pharmaceutical, agrochemical, and specialty chemical manufacturers. Its automated flow chemistry laboratory collects dense kinetic datasets on chemical reactions at speed, training proprietary machine learning and micro-kinetic models that predict optimal manufacturing conditions. Clients receive quantitative, FAIR-compliant data and model outputs via API, enabling faster and more sustainable process scale-up.